Clinical Trial Update: Misoprostol Dosing in BMI Greater Than 30 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating misoprostol dosing in people with BMI greater than 30; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysfunctional Labor
• Obesity
• Prolonged Labor

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: University of Texas at Austin | Conditions: Pregnancy Related, Obesity | Phase 4 | Status: COMPLETED | Results posted: 2024-07-03